| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |